Crizocent （XALKORI）is also known as Bangladesh Generic XALKORI （crizotinib）, is a kinase inhibitor indicated for the treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose tumors are anaplastic lymphoma kinase (ALK) or ROS1-positive as detected by an FDA-approved test.
DOSAGE AND ADMINISTRATION
1.Recommended Dose: 250 mg orally twice daily.
2.Renal Impairment: 250 mg orally once daily in patients with severe renal impairment (creatinine clearance <30 mL/min) not requiring dialysis.
Crizocent’s brand name in USA is XALKORI by Pfizer. Crizocent is a generic prescription medicine from Incepta, which is one of the biggest pharmaceutical company in Bangladesh.
For more Prescribing information，please check the → “FDA Prescribing Information”